feed

S&P 500—

NASDAQ—

DOW—

RUSSELL—

VIX—

US10Y—

DXY—

EUR/USD—

GBP/USD—

GOLD—

WTI—

BTC—

ETH—

AArphraTerminal

Arphra/Issuer/MRNA

MRNA

Moderna, Inc.

HealthcareBiotechnologyUSUSD

$47.19

+4.90%Live · FMPMay 29, 2026

Market cap

$18.72B

52w range

22.28 – 59.55

P / E

—

EPS

—

Volume

6.32M

Revenue · FY

$1.94B

-39.23% YoY

Press releasestopic:all earnings guidance dividend buyback mna ipo split layoffs lawsuit regulation rating executive product macro

News sentiment · 90d

DB · scored

2026-05-01 bullish neutral bearish2026-05-12

Topic mix · 30d

DB · scored

earnings0.501
lawsuit0.501
regulation1.001

News

DB · scored14

Moderna Recognized by TIME as One of the World's Most Impactful Companies
May 12, 2026Accesswire
Moderna Recognized by TIME as One of the World's Most Impactful Companies
May 12, 2026Accesswire
Moderna, Inc. (MRNA) Presents at Bank of America Global Healthcare Conference 2026 Transcript
May 12, 2026Seeking Alpha
Moderna's AI Could Get a Hantavirus Vaccine Here Faster-1.00
May 12, 2026PYMNTS
Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data for Its Investigational Seasonal Influenza Vaccine, mRNA-1010+1.00
May 06, 2026Accesswireregulation
Moderna Inc (MRNA) Q1 2026 Earnings Call Highlights: Strategic Growth Amidst Legal Challenges+0.50
May 02, 2026GuruFocusearnings lawsuit
Moderna, Inc. (MRNA) Q1 2026 Earnings Call Transcript
May 01, 2026Seeking Alphaearnings
Moderna Reports Q1 Loss, Stock Jumps on Strong International Sales+0.33
May 01, 2026Zacks Investment Research
Moderna reports mixed Q1 results as revenue beats estimates but litigation charge weighs on earnings+0.20
May 01, 2026Proactive Investorsearnings lawsuit
Moderna Q1 Earnings: Revenue Beat Overshadowed By Litigation Charge, Pipeline Drives Outlook+0.75
May 01, 2026Seeking Alphaearnings guidance regulation
Moderna Sales Triple To $389 Million As Shares Rise 5.4%+1.00
May 01, 2026GuruFocus
Moderna (MRNA) Reports Q1 Loss, Beats Revenue Estimates-0.33
May 01, 2026Zacks Investment Research
Moderna Stock Spikes After Earnings. Covid Vaccine Revenue Is a Growth Driver Again.+0.50
May 01, 2026Barronsearnings
Moderna Reports First Quarter 2026 Financial Results and Provides Business Updates+0.50
May 01, 2026Accesswireearnings lawsuit regulation